CzechiaOther
Medicinal Products Containing Anifrolumab
The procurement involves the supply of medicinal products containing anifrolumab. The estimated total value is 9,064,670 EUR.
- Deadline
- 10 Nov 2026
- Estimated value
- €9,064,670
- Published
- 12 Oct 2026
- CPV
- 33652300
Get help from a local consultant
Bidding cross-border? A Baltmodus consultant who works in this market can help you prepare and submit.
Find a consultant